Acewave P Tab
Cresha Lifesciences - Tablet - 10 S
₹55
Prescription required
Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated August 2026
Glimepiride 0.5 mg + Metformin hydrochloride (strength unknown)
Type 2 diabetes mellitus (adult) when diet and exercise alone are insufficient; used to improve glycaemic control.
Glimepiride (a sulfonylurea) stimulates the pancreas to release insulin and improves peripheral insulin sensitivity. Metformin reduces glucose production in the liver and decreases intestinal glucose absorption while improving insulin sensitivity.
Take orally as advised by a doctor, preferably with meals to reduce stomach upset and risk of low sugar. Swallow tablet whole with water; do not crush/chew unless advised. Monitor blood glucose regularly and follow diet/exercise plan.
Common side effects of Glimiscore-M 0.5 Tab may include:
Cresha Lifesciences - Tablet - 10 S
Prescription required
Cresha Lifesciences - Tablet - 10 S
Prescription required
Cresha Lifesciences - 170 ml
Prescription required
Cresha Lifesciences - Tablet - 100 mg - 10 S
Prescription required
Cresha Lifesciences - Tablet - 50 mg - 10 S
Cresha Lifesciences - Tablet - 10 S
Cresha Lifesciences - Injection - 2 ml
Cresha Lifesciences - Tablet - 10 S
Risk of hypoglycaemia (more likely with missed meals, excess exercise, alcohol, elderly, or kidney/liver impairment). Metformin may rarely cause lactic acidosis—seek urgent care for rapid breathing, severe weakness, muscle pain, unusual sleepiness, or abdominal discomfort. Use with caution/avoid in severe renal impairment, severe liver disease, dehydration, severe infection, hypoxia, or alcoholism. Temporarily stop metformin before and after iodinated contrast studies or major surgery as advised. Regularly monitor kidney function, liver function, and vitamin B12 with long-term use.